White & Case and its Turkish affiliate GKC Partners have advised Ronesans Holding's subsidiary Renell Kokshetau on the financing of a EUR 456 million public-private partnership healthcare project for the construction and operation of a hospital in Kazakhstan. Clifford Chance reportedly advised the financing institutions.

Papapolitis & Papapolitis, working with White & Case, has advised Germany-based investment holding Armira and Viessmann Generations Group on the acquisition of a minority stake in Pharos Generics Holding from Diorama Investments, Limonilum, Amarilenco, and Hesperiada. KLC advised Pharos Generics Holding as well as Limonilum, Amarilenco, and Hesperiada. Zepos & Yannopoulos advised Diorama Investments. Latham & Watkins was reportedly the sellers' international counsel.

A&O Shearman has advised Reinsberg Group on its acquisition of a majority stake in Brandon Medical. Veronique Marot & Co Solicitors reportedly advised Brandon Medical.

Starting on 1 January 2025, the parallel import of medicines into Ukraine will come into force, allowing dealers that are authorised by manufacturers of medicinal products to import medicines in parallel with said manufacturers. The expected outcomes of this new regime are higher competition and lower prices for relevant medicines.

Oppenheim has advised Romania's MedLife Group affiliate Genesys Medical Clinic on the acquisition of Budapest-based VP-Med Health Centre from Attila Szabo and Olga Szegvari.

CMS has advised Werfen on its approximately USD 25 million acquisition of Omixon Biocomputing. Hogan Lovells advised Omixon.